Regional News

Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development

BEIJING, Aug. 8, 2022 /PRNewswire/ -- The 2022 Taihu Bay Future Healthcare Conference held Thursday in Wuxi City in eastChina's Jiangsu Province witnessed the launch of Wuxi Intellectual Property Protection Center with 52 biomedical projects contracted, involving a total of more than30 billion yu...

2022-08-08 12:24 3804

Baidu Granted China's First-Ever Permits for Commercial Fully Driverless Ride-Hailing Services

-  Baidu has become the first and only company to offer fully driverless robotaxi services to the public inChina, without human drivers in the car. -  The new permits will also allow Baidu to put fully driverless robotaxis on open roads inChongqing and Wuhan during the daytime. -  China is the f...

2022-08-08 12:06 2966

Join our EV Revolution and Keep the City Green - Drive lah

An EV emits half the amount of CO2 as compared to a similar vehicle powered by ICE. If all passenger vehicles run on electricity, we would reduce carbon emissions by 1.5 to 2 million tonnes, or about 4% of total national emissions. SINGAPORE, Aug. 8, 2022 /PRNewswire/ -- Drive lah is a peer-to-pe...

2022-08-08 11:45 4211

LoanQ a Finalist in the Australian Mortgage Awards

Transformational broker solution shortlisted as excellence awardee SYDNEY, Aug. 8, 2022 /PRNewswire/ -- Innovative Australian fintech loan origination and lead generation solution for mortgage brokers, LoanQ, has been announced as an excellence awardee finalist in this year's Australian Mortgage ...

2022-08-08 11:43 2328

Forrester's Future Of Jobs Forecast: 63 Million Jobs In APAC Will Be Lost To Automation By 2040

A declining working population and rising costs to hire and retain employees will force firms inAsia Pacific to invest more in automation SINGAPORE, Aug. 8, 2022 /PRNewswire/ -- Forrester  (Nasdaq: FORR) fore...

2022-08-08 10:45 3611

Qmed Asia launches Qmed GO "Mini Clinics" to Solve Rising Employee Healthcare Costs

Disrupting the medical landscape through an innovative internet-enabled clinical kiosk. KUALA LUMPUR, Malaysia, Aug. 8, 2022 /PRNewswire/ -- Qmed Asia  launched the Qmed GO at the recent Malaysia International Retail and Franchise (MIRF) Exhibition 2022 held at theKuala Lu...

2022-08-08 10:15 3507

BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition

Exhibition visitors surpass 100,000 people over 4 days BIO Asia–Taiwan success a testament to Taiwan's booming biotechnology industry TAIPEI, Aug. 8, 2022 /PRNewswire/ -- BIO Asia–Taiwan 2022, held at the TaiNEX 2 Exhibition Center, Nangang,Taipei, from 27-31 July, came to a successful conclusio...

2022-08-08 10:00 5877

INEOS STYROLUTION THAILAND AWARDED THE GOLD STAR AWARD FOR THE 3RD CONSECUTIVE YEAR

Singapore, Aug. 8, 2022 /PRNewswire/ -- INEOS Styrolution, the global leader in styrenics, announces today that the company has been awarded the Gold Star Award for the third consecutive year by the Industrial Estate Authority of Thailand (IEAT) for outstanding performance in the areas of complia...

2022-08-08 10:00 3636

DDPAI Z50 4K DUAL DASH CAM LAUNCH

The Finer, The Mightier SHENZHEN, China, Aug. 8, 2022 /PRNewswire/ -- On August 8th, DPPAI unveils the Z50 dash cam  model, As in Z-series, continues the preview screen and sleek design but upgraded details with powerful performance. The finer, the mightier.

2022-08-08 10:00 3854

Atlanta Site Strengthens Sims Lifecycle Services' Operational Footprint

–      New center dedicated to optimizing repurposing of electronic equipment for the city's growing business and data center industries– WEST CHICAGO, Ill., Aug. 8, 2022 /PRNewswire/ -- Sims Lifecycle Services (SLS), a global leader in IT asset disposition (ITAD), data center circularity and el...

2022-08-08 09:15 2003

BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs

SHANGHAI, Aug. 8, 2022 /PRNewswire/ -- BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library (...

2022-08-08 09:06 3753

Get SAT Introduces Two New FULLY Electronic KU ESA Solutions for Aviation, Land, and Maritime

REHOVOT, Israel , Aug. 8, 2022 /PRNewswire/ -- Get SAT is proud to introduce its two newest electronically steerable antennas (ESA), the LESA Aero Ku and the Sling Blade KU Land Maritime (LM).  Designed from the ground up for Multi-Orbit/Multi-Constellation operations. These Ku ESA designs use Get...

2022-08-08 09:00 3899

Japanese Software Company Cybozu Provides Inflation Relief Allowance for Southeast Asia Employees

In response to rapid cost-of-living increases around the world, Tokyo-based IT company Cybozu is paying employees a one-time special inflation relief allowance KUALA LUMPUR, Malaysia, Aug. 8, 2022 /PRNewswire/ -- Cybozu Inc. , a Japanese provider of groupware sol...

2022-08-08 09:00 3132

Leading Solar Energy Solution Provider Haitai Solar Launches IPO on Beijing Stock Exchange

BEIJING, Aug. 8, 2022 /PRNewswire/ -- Haitai Solar, a leading new energy solutions and solar module provider, today announced that the Company has completed the process of its initial public offering and started trading on the Beijing Stock Exchange under the stock code 835985 onAugust 8, 2022. ...

2022-08-08 09:00 4604

Toshiba Announces Name Changes of Two Elevator Subsidiaries in Malaysia

Malaysian market leader reaffirms commitment to manufacture and supply of high-quality building solutions in Southeast Asian market KAWASAKI, Japan, Aug. 8, 2022 /PRNewswire/ -- Toshiba Elevator and Building Systems Corporation (hereafter TELC), a subsidiary of Toshiba Corporation (TOKYO : 6502),...

2022-08-08 09:00 5558

ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation

SHENZHEN, China, Aug. 7, 2022 /PRNewswire/ -- On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA").

2022-08-08 08:30 1986

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors

--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFNγ in a concentration dependent manner with an EC50 of 2.86 nM. Ma...

2022-08-08 08:10 3358

CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022

* GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator ProfessorYi-Long Wu was invited to highlight key data in a press conference * In the final progression-free survival analysis, sugemalimab showed sustained ...

2022-08-08 08:08 3282

Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema

SAN FRANCISCO and SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2022-08-08 08:00 3580

Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer

SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces the appointment of Dr. ...

2022-08-08 08:00 3281